- BUZZ-Sezzle shares surge as annual earnings outlook is raised and Q3 profit beats expectations
- BUZZ - Duke Energy shares rise after third quarter earnings beat expectations
- Updated version 1 - Novavax raises 2026 revenue forecast due to returns from licensing agreements
- Democratic midterm election victory raises regulatory concerns, Micron Technology falls 5% pre-market
- Intellia Therapeutics Q3 net loss widens 26% to $127.49 million
- Retension Pharmaceuticals to Participate in Fireside Chat at Guggenheim Healthcare Innovation Conference
- Metals Creek, Benton grant Brutus option to acquire Bay of Islands hydrogen project
- Supremex Expects $5.7 Million in Annualized Restructuring Savings at Full Run Rate by Q1 2027
- Crédit Agricole’s Amundi Launches Tokenized Share Class of Core STOXX Europe 600 Fund
- White Mountains Insurance 3Q Rev $641.1M >WTM
- Hertz Global 3Q Rev $2.6B >HTZ
- Hertz Global 3Q Net $116M >HTZ
- White Mountains Insurance 3Q Loss/Shr $17.71 >WTM
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- Colombia conditionally approves Kimberly-Clark's acquisition of Kenvue
- Belite Bio to Host Third-Quarter Financial Results Webcast
- electroCore Participates in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- Calumet leases refinery assets to Montana Renewables for MaxSAF expansion
- Ovid Therapeutics Plans Participation in Three Investor Conferences
- OS Therapies Completes Herlystic Drug Substance Requalification for Phase 3 Trial
- Green Canada Uranium Plans to Use Financing Proceeds for Canadian Exploration
- US Home Prices Fall for Third Straight Week, Redfin Reports
- Shattuck Labs Q3 net loss more than doubles to $25.2 million
- Portillo's Sees FY26 Rev $768M-$773M >PTLO
- Lakewood-Amedex Biotherapeutics Redeems All Remaining Preferred Shares for $1.27 Million
- Cambi Publishes Q3 2026 Results Presentation Transcript
- Wellchange Sets 1-for-10 Reverse Stock Split Effective Nov. 9, 2026
- OFA Group Sets 10-for-1 Class A Share Consolidation for Nov. 10
- MiniMed CFO to Speak at Three Healthcare Investor Conferences
- US newly pending home listings fall 16.8% in October, largest annual drop since 2023, Zillow says
- White Mountains Q3 net income swings to $29.6 million loss year-over-year
- RIDGEPOST CAPITAL INC. <RPC.N>: OPPENHEIMER CUTS TARGET PRICE TO $14 FROM $15
- TRIMBLE INC. <TRMB.O>: OPPENHEIMER CUTS TARGET PRICE TO $73 FROM $80
- GXO LOGISTICS <GXO.N>: OPPENHEIMER RAISES TARGET PRICE TO $65 FROM $61
- FLUTTER ENTERTAINMENT PLC <FLUT.N>: OPPENHEIMER CUTS TARGET PRICE TO $100 FROM $110
- INNOVIVA INC. <INVA.O>: OPPENHEIMER CUTS TARGET PRICE TO $34 FROM $35
- MODINE MANUFACTURING CO. <MOD.N>: OPPENHEIMER CUTS TARGET PRICE TO $215 FROM $260
- PRIMORIS SERVICES CORPORATION : OPPENHEIMER CUTS TARGET PRICE TO $115 FROM $135
- DUTCH BROS <BROS.N>: OPPENHEIMER CUTS TARGET PRICE TO $54 FROM $66
- APPLOVIN CORP. : OPPENHEIMER RAISES TARGET PRICE TO $520 FROM $490
- CORPAY, INC. <CPAY.N>: OPPENHEIMER RAISES TARGET PRICE TO $461 FROM $454
- SpyGlass Pharma to Participate in Three Investor Conferences
- Gunpoint Exploration Appoints Christopher Gulka CFO and Corporate Secretary
- Freshpet Participates in Stephens and Morgan Stanley Investor Conferences
- Christ Jonatan Daely Raises Stake in Artha Mahiya Investama to 5.97% From 5.78%
- Insight Enterprises Q3 net earnings fall 57% to $22.16 million
- NCDEX partners with BigMint on steel scrap derivatives price benchmarks
- Novavax Q3 2026 net loss narrows 84% to $31.38 million
- BlackRock TCP Capital 3Q Loss/Shr 80c >TCPC
- CRA Intl 3Q Adj EPS $2.19 >CRAI
- CRA Intl 3Q EPS $2.20 >CRAI
- Centuri Holdings 3Q EPS 27c >CTRI
- Taysha Gene Therapies Updates Financial Calendar
- Franklin Municipal Opportunities Trust Repurchases 95% of Outstanding Remarketed Preferred Shares
- Arcutis Begins Phase 3 Trial of Zoryve Cream 0.3% for Moderate to Severe Atopic Dermatitis
- Processa Pharmaceuticals Participates in UBS Global Healthcare and Evercore ISI HealthCONx Conferences
- Entegris Expands Kioxia Partnership to Develop Materials for Next-Generation Memory
- Centuri Q3 net income rises year over year to $26.93 million
- Lineage Cell Therapeutics to Report Third-Quarter Financial Results
- Dermapharm Sets Q3 Financial Report Release
- Gamehaus Plans to Make Anamana Primary Growth Engine After Acquisition Closes
- Correct: Sabre 3Q Adj EPS 11c >SABR
- Intellia Therapeutics 3Q Research and Development Expenses $83.3M >NTLA
- USA TODAY Sees 2026 Revenues Dn in the Mid-Single Digits on a Same Store Basis >TDAY
- Correct: Sabre 3Q Cont Ops Loss/Shr 6c >SABR
- Intellia Therapeutics 3Q Rev $7.16M >NTLA
- Ralph Lauren Continues to Expect Cap Expenditures for FY27 of 4% to 5% of Rev >RL
- USA TODAY Had Cash and Cash Equivalents of $68.2M as of Sept 30 >TDAY
- Lipocine 3Q Loss/Shr 8c >LPCN
- Edgewise plans Phase 3 EDG-7500 trial with dosing independent of echocardiogram monitoring
- Tejon Ranch Q3 net income rises 97% year over year to $3.3 million
- NuRAN Wireless Estimates Contract Revenue at More Than USD 900 Million
- Corbus Pharmaceuticals Plans Presentations at Three Healthcare Investor Conferences
- Verrica Pharmaceuticals Sets Third-Quarter Results Conference Call
- Lipocine Q3 2026 net loss narrows 79% to $666,192
- Sprinklr Names Jamie Thompson Global Head of Services and Support
- IQSTEL Preliminary Q3 Revenue Falls 2.8% Sequentially to $106 Million
- CRA International Raises Quarterly Dividend 17.5% to $0.67 Per Share
- Grace Therapeutics Announces Participation in BIO-Europe, Craig-Hallum Alpha Select Conferences
- Bunker Hill Mining Shareholders Approve Increase in Authorized Shares to 400 Million at Special Meeting
- TARSUS PHARMACEUTICALS, INC. <TARS.O>: MIZUHO RAISES TARGET PRICE TO $102 FROM $94
- Fobi AI Signs Distribution Deal With UAE-Based Silkbridge Ventures for International Expansion
- America's Car-Mart Lenders Extend Credit Agreement Waivers Through Nov. 9, 2026
- Dominari Begins Retirement of More Than 1,900,000 Repurchased Shares
- BRIEF-Ralph Lauren Q2 Revenue USD 2,200 Million Vs. IBES Estimate USD 2,122 Million
- Sempra Expects 20% Increase to Oncor's Base Capital Plan >SRE
- --Earnings Flash (TDAY) USA Today Posts Q3 Loss $0.03 a Share, vs. FactSet Est of $0.06 Loss
- --Earnings Flash (GSAT) Globalstar Posts Q3 Loss of $0.14 a Share, vs. FactSet Est of $0.12 Loss
- -- Earnings Flash (TDAY) USA TODAY Co., Inc. Reports Q3 Revenue $519.2M, vs. FactSet Est of $528.4M
- -- Earnings Flash (CRAI) Charles River Associates Reports Q3 Revenue $214.9M, vs. FactSet Est of $199.0M
- -- Earnings Flash (CRAI) Charles River Associates Posts Q3 Adjusted EPS $2.19 per Share, vs. FactSet Est of $2.07
- -- Earnings Flash (NTLA) Intellia Therapeutics, Inc. Reports Q3 Revenue $7.2M, vs. FactSet Est of $9.7M
- -- Earnings Flash (CTRI) Centuri Holdings, Inc. Posts Q3 Adjusted EPS $0.42 per Share
- -- Earnings Flash (NVAX) Novavax, Inc. Reports Q3 Revenue $68.3M, vs. FactSet Est of $50.4M
- --Earnings Flash (WTM) White Mountains Insurance Posts Q3 Loss $17.71 a Share
- -- Earnings Flash (CTRI) Centuri Holdings, Inc. Reports Q3 Revenue $1.19B, vs. FactSet Est of $1.04B
- Wesdome Gold Mines Q3 Adjusted Net Income Rises YoY
